MeiraGTx signs asset purchase agreement for bota-vec collaboration with Janssen

MeiraGTx signs asset purchase agreement for bota-vec collaboration with Janssen
MeiraGTx shares jump as Sanofi invests in gene therapy
929.7MUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
KYG596651029
CUSIP
G59665102
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
10.10
PEG Ratio
-
Book Value
-0.07
Dividend Share
-
Dividend Yield
-
Earnings Share
0.87
Wall Street Target Price
27.75
EPS Estimate Current Year
0.51
EPS Estimate Next Year
-1.53
EPS Estimate Current Quarter
-0.4225
EPS Estimate Next Quarter
-0.5375
Most Recent Quarter
-
Revenue TTM
397,500,992
Gross Profit TTM
389,350,016
EBITDA
196,131,008
Profit Margin
19.87%
Return On Assets TTM
38.65%
Return On Equity TTM
72.17%
Revenue Per Share TTM
4.748
Qtly Revenue Growth YOY
8608.60%
Diluted Eps TTM
0.87
Qtly Earnings Growth YOY
0.00%
Trailing PE
10.10
Forward PE
64
Price Sales TTM
2.1238
Price Book MRQ
4.3105
Enterprise Value Revenue
2
Enterprise Value EBITDA
8
325.00
3.35%956.63
0.48%34.67
0.17%900.30
0.00%136.78
0.00%217.81
-5.51%960.04
-2.37%537.00
-1.28%413.00
-0.85%162.42
-0.02%